The Department of Health Research released the Draft National Health Research Policy 2026 for public consultation recently. The draft proposes a unified national framework for health research, new governance, long‑term funding targets and a National Health Research Agenda to align research with India’s disease burden and service delivery.
What the draft proposes
Scope and purpose
The draft covers biomedical science, clinical medicine, public health, epidemiology, health systems, behavioural sciences, digital health and artificial intelligence. It replaces the 2011 framework and aims to align publicly funded research with national and sub‑national health priorities and service delivery needs.
Governance and institutional design
- Three‑tier architecture: A National Health Research Stewardship Committee will provide strategic coordination; the Department of Health Research will be the nodal implementing and coordinating agency; the Indian Council of Medical Research (ICMR) will serve as scientific and technical lead.
- State integration: The draft mandates integration of research with state health programmes and clinical networks to shorten translation time from evidence to policy and practice.
- Roles and accountability: Clear division of roles—strategy (Stewardship Committee), operational coordination (DHR), scientific standards and ethics (ICMR)—with mechanisms for periodic review of the National Health Research Agenda (NHRA).
Funding: current status and targets
| Dimension | Share of GDP |
|---|---|
| Current allocation (India) | 0.024% |
| Target (medium term) | 0.072% by 2037 |
| Target (long term) | 0.15% by 2047 |
| High‑income country average (weighted) | 0.27% |
Funding is to be channelled to priority areas identified by the NHRA and to systems that link research outputs with public health programmes.
Priority setting: National Health Research Agenda (NHRA)
- Purpose: Periodic identification of national and regional research priorities for public funding.
- Selection criteria: Disease burden, health‑system needs, scientific opportunity, equity and access, pandemic preparedness, and strategic national interests.
- Expected effect: Reduce duplication, target investments to high‑impact areas (e.g. maternal and child health, non‑communicable diseases, infectious diseases, rural health delivery, Indigenous technologies).
Performance metrics and assessment
- Move beyond publications: Evaluation will shift from publication and citation counts to measures of real‑world impact.
- Impact parameters: Contributions to policy formulation, changes in clinical practice guidelines, development and deployment of indigenous health technologies, improvements in access and equity.
- Assessment model: Adoption of an ICMR‑IRIS style impact assessment to align incentives for socially relevant research.
Technological integration: digital health and AI
- Inclusion of new domains: The draft mainstreams artificial intelligence, advanced analytics and digital epidemiology within health research priorities.
- Data governance: Proposes standards for use of electronic health records and public health datasets for research while maintaining confidentiality and consent safeguards.
- Indigenous innovation: Encourages development of local AI tools and digital health products, with attention to validation, ethical review and scalability within public systems.
Federal cooperation, equity and service delivery
- State‑centric implementation: Research planning and funding mechanisms will require state collaboration to ensure local relevance and uptake.
- Equity lens: Priority setting uses equity and regional disease burden as core criteria to direct resources to underserved populations and neglected conditions.
- Translation pathways: Proposes formal linkages between researchers, programme managers and frontline service providers to enable rapid operational research, pilot studies and scale‑up.
Operational and regulatory considerations
- Ethics and standards: ICMR remains responsible for scientific guidance and ethical standards; the draft envisages updated guidelines for AI and data use in research.
- Capacity building: Emphasis on strengthening institutional capacities at state medical colleges, public health institutes and research networks.
- Public consultation: DHR invited stakeholder feedback; the submission window for comments closes on 27 July 2026.
Risks and implementation challenges
- Funding realism: Achieving 0.15% of GDP by 2047 will require sustained fiscal commitment and clear budgetary pathways.
- Coordination gap: Translating a central NHRA into state action needs capacity building and incentive alignment at sub‑national level.
- Data and privacy: Large‑scale use of digital health data raises governance, interoperability and privacy challenges that require regulatory clarity.
- Measurement of impact: Operationalising real‑world impact metrics demands robust monitoring systems and agreement on attributable outcomes.
Model Questions
1. Analyse the three‑tier governance structure proposed in the Draft National Health Research Policy 2026 and its potential to improve research translation into policy and practice. [GS-II: Governance]
The structure separates strategy (National Health Research Stewardship Committee), implementation (DHR) and scientific leadership (ICMR). This clarity can reduce overlap and speed decision‑making. Effective translation requires formal state linkages, clear accountability, routine NHRA updates, and capacity building at state research and health units. Risks include weak state capacity and coordination failure; mitigation needs ring‑fenced funds and performance‑linked implementation protocols.
2. Examine the financial targets in the draft policy and the implications of shifting research evaluation from publications to real‑world impact. [GS-III: Economic Development]
The draft raises health research funding from 0.024% to 0.072% of GDP by 2037 and 0.15% by 2047. Higher funding aims to prioritise applied, system‑relevant studies. Shifting metrics to real‑world impact aligns incentives to policy uptake, technology development and equity outcomes. Implementation requires transparent allocation criteria, impact measurement systems, and safeguards against short‑termism in applied research funding.
3. How does the Draft National Health Research Policy 2026 address federal coordination and equity in the health research ecosystem? [GS-II: Governance]
The draft mandates integration of research with state health programmes and uses NHRA criteria—disease burden and equity—to set priorities. It envisages state participation in agenda formulation and funding mechanisms that target underserved regions. Success depends on state research capacity, incentivised implementation, data sharing agreements, and targeted financing to ensure disadvantaged groups benefit from research outputs.
4. Discuss how the draft policy incorporates digital health and artificial intelligence, and identify governance issues that need resolution. [GS-III: Science & Technology]
The draft brings AI, digital epidemiology and advanced analytics into mainstream research priorities and promotes indigenous tool development. It proposes data standards and ethical oversight for research using electronic health records. Key governance gaps are interoperability, consent frameworks, algorithmic transparency, validation requirements, and regulatory structures for clinical deployment of AI tools; these require statutory or guideline‑level interventions.
Last Modified: July 15, 2026